Molecule Details
| InChIKey | KQDRVXQXKZXMHP-LLVKDONJSA-N |
|---|---|
| Canonical SMILES | CC(C)Cc1ccc([C@@H](C)C(=O)NS(C)(=O)=O)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.64 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB12614 |
|---|---|
| Drug Name | Reparixin |
| CAS Number | 266359-83-5 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Reparixin has been used in trials studying the treatment and prevention of Breast Cancer, Metastatic Breast Cancer, Pancreatectomy for Chronic Pancreatitis, Islet Transplantation in Diabetes Mellitus Type 1, and Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus. |
Categories: Amides Sulfones Sulfur Compounds
Cross-references: BindingDB: 50169045 CHEMBL191413 ChemSpider: 8014432 PubChem:9838712 PubChem:347828828 ZINC: ZINC000000008717